However, our former studies were shown that simvastatin (used to decrease the high level of blood cholesterol) although exhibits pleiotropic effects on carcinogenesis, inhibits the release of IL-8 and IL-6 from colorectal cell lines and decreases serum IL-6 level in patients with advanced colorectal cancer (34). This evidence concerns the gene IL6 and colorectal cancer.